Jordyn M. Wilcox

Jordyn M. Wilcox

Auto-generated profile, based on publicly available information

Jordyn M. Wilcox

Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2022 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
JWJordyn M. Wilcox
Jordyn M. Wilcox
DCDavid Consoli
David Consoli
KPKrista C. Paffenroth
Krista C. Paffenroth
BSBrittany D. Spitznagel
Brittany D. Spitznagel
ECErin S. Calipari
Erin S. Calipari
FHFiona Harrison
Fiona Harrison

17 September 2021 in NeuroToxicology
Verified
Journal Article
Closed access
JWJordyn M. Wilcox
Jordyn M. Wilcox
APAnna C. Pfalzer
Anna C. Pfalzer
ATAdriana A. Tienda
Adriana A. Tienda
IDInes F. Debbiche
Ines F. Debbiche
ECEllen C. Cox
Ellen C. Cox
ABAaron B. Bowman
Aaron B. Bowman

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
AMAmanda L Marino
Amanda L Marino
JWJordyn M Wilcox
Jordyn M Wilcox
FHFiona Harrison
Fiona Harrison
Background: Neuroinflammation is considered a key pathogenic feature of Alzheimer’s disease (AD) progression. Presence of reactive oxygen species is a driving factor in neuroinflammatory processes and deficiency of antioxidants in the brain can contribute to AD pathogenesis via this mechanism. However, more specifically depletion of ascorbic acid (ASC, vitamin C) may directly impact microglial function. Like neurons, microglia express the sodium‐dependent vitamin C transporter (SVCT2) and can store ASC at high concentrations. Nevertheless, specific roles for ASC and SVCT2 in the inflammatory response are not well understood. This present study investigated a protective role for vitamin C (ASC) following LPS administration to microglial cells.Method: HMC3 cells (P8‐12) were cultured in 6‐well plates in DMEM (10% FBS, 1% Pen/Strep) treated with ASC (0 or 200 mM) LPS (0, 1mg/mL or 10mg/mL) for 24 hours. After 24 hours, cells were collected to identify intracellular and extracellular (media levels) of ASC by high pressure liquid chromatography. Expression of a number of inflammatory and apoptosis linked genes was assessed by qPCR with reference to two housekeeping genes [GAPDH, ACTB]. Immunofluorescent staining of SVCT2 was performed in fixed cells that were co‐stained with Iba‐1.Result: Intracellular ASC was increased by ASC treatment and was not significantly changed due to LPS treatment. 1mg/mL LPS significantly induces inflammatory phenotype in HMC3 microglia including upregulation of mRNA levels of inflammatory cytokines including [IL‐1B, IL‐6, NF‐kB] and this effect was attenuated by ASC treatment. 10mg/mL induced cell death in HMC3 microglial cells and this effect was also at least partially mitigated by concurrent treatment with ASC.Conclusion: uroinflammation is a critical component of AD neuropathology and ASC decreased inflammatory cytokine signaling and an inflammatory phenotype following LPS treatment in HMC3 microglia. These data suggest that maintaining adequate cellular ASC levels may preserve microglial function in the presence of inflammatory stimuli such as beta‐amyloid or delay neuroinflammation‐linked facets of Alzheimer’s disease pathology.